Stock listing
ARCT Stock Price, News, Filings & Events — Arcturus Therapeutics Holdings Inc.
Selected listing: ARCT · NASDAQ · USD · US
This page tracks Arcturus Therapeutics Holdings Inc.'s ARCT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARCT:NASDAQ. ARCT:NASDAQ is the stock-level entry point for investors researching Arcturus Therapeutics Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arcturus Therapeutics Holdings Inc. is a public company traded on the American market under the ticker ARCT. The company has a market capitalization of approximately $157.18 million. Arcturus focuses on developing innovative RNA medicines for various diseases.
- Ticker
- ARCT:NASDAQ
- Asset type
- Stock
- Market cap
- $431.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Arcturus Therapeutics Holdings Inc. ARCT:NASDAQ stock context
This page tracks Arcturus Therapeutics Holdings Inc.'s ARCT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ARCT:NASDAQ. ARCT:NASDAQ is the stock-level entry point for investors researching Arcturus Therapeutics Holdings Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arcturus Therapeutics Holdings Inc. is a public company traded on the American market under the ticker ARCT. The company has a market capitalization of approximately $157.18 million. Arcturus focuses on developing innovative RNA medicines for various diseases.
Latest news from Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026
July 28, 2026
Arcturus Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference
July 20, 2026
Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis
July 2, 2026
Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
May 26, 2026
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
May 7, 2026
Arcturus Therapeutics Holdings Inc. earnings calls
Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call
May 7, 2026 · Replay with transcript and chapters
Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call
March 3, 2026 · Replay with transcript and chapters
Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2025 Earnings Call
August 11, 2025 · Replay with transcript and chapters
Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2025 Earnings Call
May 12, 2025 · Replay with transcript and chapters
Research Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc. investor report
Review AI stock analysis and investor report context for ARCT:NASDAQ.
Arcturus Therapeutics Holdings Inc. company profile
View the public company page for Arcturus Therapeutics Holdings Inc. on 6ix.
Arcturus Therapeutics Holdings Inc. news
Read company news and market updates connected to Arcturus Therapeutics Holdings Inc..
Arcturus Therapeutics Holdings Inc. investor events
Find investor webinars, events, and replay context for Arcturus Therapeutics Holdings Inc..